Steven F. Bellon - Sep 9, 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Scientific Officer
Signature
/s /Tara Maduri, Attorney-in-Fact for Steven F. Bellon
Stock symbol
FHTX
Transactions as of
Sep 9, 2024
Transactions value $
-$190,000
Form type
4
Date filed
9/11/2024, 04:00 PM
Previous filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Sale -$190K -20K -16.4% $9.50 102K Sep 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.